ReviewOncoTargets and therapy2023
Recent Advances in the Management of Adverse Events Associated with Lorlatinib.
Dehua Liao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it
ReviewOncoTargets and therapy2023
Dehua Liao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.